论文部分内容阅读
培哚普利是非疏氢基ACEI新药,其作用时间较长,已广泛用于对照试验的研究中,本文观察了大系列2927例老年高血压病人治疗6个月的安全性和疗效。对象和方法法国2927例轻至中度高血压≥70岁者作为对象.男性占35％。高血压持续时间9.4±0.2年,平均收缩压(SBP)23.7±0.04kPa,平均舒张压(DBP)13.2±0.03kPa,DBP<14.0kPa者占74％,14.0kPa≤DBP<15.3kPa者占26％。病人开始给药2或4mg,日1次;在1或3个月后。若卧
Perindopril is a non-hydrophobic hydrogen radical ACEI new drug, its role for a longer time, has been widely used in the control study of the study, this article observed a large series of 2927 elderly hypertensive patients treated for 6 months of safety and efficacy. Subjects and Methods France 2927 cases of mild to moderate hypertension ≥ 70 years as a target, men accounted for 35%. The duration of hypertension was 9.4 ± 0.2 years, mean systolic blood pressure (SBP) 23.7 ± 0.04kPa, mean diastolic blood pressure (DBP) 13.2 ± 0.03kPa, DBP <14.0kPa 74%, and 14.0kPa ≦ DBP <15.3kPa 26 %. The patient started dosing 2 or 4 mg once daily; after 1 or 3 months. If lying